News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
Biotech/Pharma - Finance (World)
Biotech Venture Capital Firm Aglaia Launches New $65 Million Oncology Fund 9/18/2014
Swiss Biopharma Cardiorentis Enters Euro 45 Million Financing Deal 9/17/2014
AM-Pharma Holding BV Locks In €12.2 Million Financing Round 9/11/2014
Poxel Nails $13.5 Million From New Investors 9/9/2014
Bionomics Limited (BNO.AX) Receives $7.5M 2014 R&D Tax Incentive 9/5/2014
GC-Rise Locks In $15 Million 9/2/2014
NEOMED Receives $12 Million From Federal Government 8/26/2014
FortuneRock (China) Hauls In $24 Million 8/25/2014
NeuroDerm Ltd. Banks $16 Million 8/22/2014
Switzerland-Based Santhera Pharmaceuticals AG (SANN.SW) Grabs CHF 13.4 Million 8/15/2014
Public Health Agency of Canada Release: Government Of Canada Donates Experimental Ebola Vaccine To World Health Organization 8/13/2014
Novartis AG (NVS), Siemens (SI), And Laboratory Corporation of America Holdings (LabCorp) (LH) Dumps $16 Million Into Seventh Sense Biosystems Inc. 8/13/2014
Novogen Limited (NVGN) Receives Funding Support To Commence Studies In Muscular Dystrophy 8/12/2014
FAAH Pharma Inc. Announces Investment From TVM Life Science Ventures VII To Develop New Treatment Against Neuropathic Pain 8/11/2014
Atox Bio Locks In $23 Million 7/24/2014
Taiho Pharmaceutical Invests US $30 Million In Remiges Biopharma Fund, LP 7/23/2014
InflaRx Announces Successful Closing Of Its Round B Financing 7/17/2014
immatics biotechnologies GmbH Reels In €22 Million Series D 7/16/2014
Phosphagenics Limited (POH.AX) Locks In $19.3 Million Capital Raising 7/11/2014
Biosceptre International Limited Closes AUD 5 Million Financing From Existing Investors 7/9/2014
Fund Manager Dumps Biggest Investment Into AstraZeneca PLC (AZN) 7/9/2014
Galapagos NV (GLPG.BR) Raises €1.9 Million Through Warrant Exercises 7/7/2014
Resverlogix Corporation (RVX.TO) Secures An Additional $30 Million From Citibank Loan 7/7/2014
ProSensa Holding N.V. (RNA) Files F-3 SEC Mixed Shelf Registration For Up To $150 Million 7/7/2014
AstraZeneca PLC (AZN) CEO Wagers $3.4 Million On Shares 7/1/2014
To-BBB technologies BV Scrounges Up Euro 10 Million 6/30/2014
Shire Gets $248 Million Tax Refund From Canada, More To Come 6/30/2014
Actavis (ACT) Dumps $18 Million In New Warehouse Facilities 6/27/2014
Manchester's 4D Pharma Reels In $29 Million 6/26/2014
Biotech Fraud-Detection Firm BioCatch Bags $10 Million In Funding 6/26/2014
Eighteen French Biotechs Such As Genticel And Genomic Vision Trek To New York To Hunt For American Investors 6/26/2014
Endo International plc Announces Proposed Private Offering Of Senior Notes 6/25/2014
CrystalGenomics Nabs $12.8 Million From The Global Pharmaceutical Industry Development Fund 6/25/2014
Dr. Reddy's Laboratories Ltd. (RDY) To Dump $320 Million In Biologics, Proprietary Medicines 6/20/2014
JHL Biotech Locks In $35 Million Series B Financing 6/19/2014
China Biologic Products Announces Proposed Public Offering Of Common Stock 6/18/2014
BioSilta Completes EUR 2.5 Million ($3.4 Million) Funding Round 6/11/2014
RuiYi (formerly Anaphore) Closes $4 Million Venture Loan From Silicon Valley Bank 6/11/2014
Nordic Nanovector Intends To Undertake Private Placement Of NOK 150 Million 6/6/2014
“Grindeks” Invests 2.4 Million Euros In Quality Control Laboratory 6/5/2014
DefiniGEN Announces Closing Of £2.3 Million ($3.8 Million) Series A Fundraising 6/2/2014
Jubilant Pharma To Raise Over $100 Million, Plans To Consolidate Pharma Biz 6/2/2014
VC Firm Epidarex Capital Unveils £47.5 Fund For Early-Stage UK Startups, Spinouts 5/29/2014
Crown Bioscience, Inc. Raises $26.6 Million In Series D Round 5/23/2014
Mucosis B.V. Receives Financial Support From The Dutch Government For Its Syngem® Program 5/22/2014
Roche (RHHBY) To Invest $135 Million Into Two New Manufacturing Facilities 5/21/2014
Gene Therapy Biotech Lysogene Reels In $22 Million 5/21/2014
Kymab Locks Down $40 Million For Antibody Research 5/16/2014
Xellia Pharmaceuticals Expands Croatian Product And Innovation R&D Center Of Excellence With Investment Of US$2.0 Million 5/14/2014
Lophius Biosciences GmbH Secures EUR 2,0 Million Financing And Announces Leadership Changes 5/8/2014
Livzon Mabpharm Leads $36 Million Funding Of Epirus, A U.S. Biosimilar Co. 5/7/2014
Big Names Infuse Startup Anokion With $37.5 Million 5/7/2014
Orexo AB (ORXOF) Issues A SEK 500 Million Bond Loan On The Swedish Bond Market 4/30/2014
InnaVirVax: Bpifrance Provides Funding For The PROTHEVIH Program On The Therapeutic Vaccine VAC-3S 4/29/2014
Voluntis Raises € 20.75 Million ($ 29 Million) 4/28/2014
Verdezyne, Inc. Nabs $48 Million Financing 4/28/2014
Isarna Therapeutics Raises Euro 5.5 Million, Announces Elizabeth Czerepak Joining As CFO/CBO To Lead U.S. Site 4/24/2014
Startup CRISPR Therapeutics Nabs $25 Million Series A , Forms A World-Renowned Team Of Academics And Clinicians 4/24/2014
Pharming Group (PHGUF.PK) Announces ("Sub 10%") €14.7 Million Private Equity Placement With Institutional Investors 4/22/2014
UK Authortity To Spend £18.7 Million To Make Gilead Sciences, Inc. (GILD)'s Sovaldi Available To Most Grave Patients 4/18/2014
Johnson & Johnson (JNJ) Starts Construction On $300 Million China Plant 4/18/2014
Startup Heart Metabolics Limited Launches With $20 Million In Pocket 4/17/2014
Wilson Therapeutics Bags $40 Million To Advance Late Stage Development Program For Wilson's Disease 4/16/2014
OxThera, Inc. Receives SEK 70 Million Financing To Continue Its Key Clinical Programs 4/16/2014
Nexvet Announces $31.5 Million Financing 4/16/2014
Spinifex Pharmaceuticals Bags $45 Million To Fund Pain Drug Trials, Established U.S. Base In Connecticut 4/11/2014
NuCana Hauls In $57 Million 4/11/2014
Galapagos NV (GLPG.BR) Raises €2.4 Million Through Warrant Exercises 4/10/2014
BVCF Closes $188 Million China Private Equity Fund 4/9/2014
Newron Pharmaceuticals (NWRN) Raises CHF18.6 Million In Private Placement To Existing And New Institutional Shareholders In Europe And The U.S. 4/7/2014
TI Pharma In €7.8 Million Consortium Tackling Neglected Parasitic Diseases 4/2/2014
Biotech Veteran-Led Foresite Capital Reloads $300 Million To Bankroll Late-Stage Companies 4/1/2014
Bayer HealthCare AG (BAY) To Dump $138 Million In Beijing Facility 4/1/2014
Cellectis Announces The Closing Of €20.5 Million Share Capital Increase Subscribed On March 24, 2014 By U.S. Biotechnology Specialist Institutional Investors 4/1/2014
Skyepharma PLC (SKYEF) To Raise £112 Million Through Placing 3/31/2014
San Diego's RuiYi (formerly Anaphore) Grabs $15 Million For Monoclonal Antibody Research 3/27/2014
Syngenta AG (SYT) Announces Successful EUR 750 Million Eurobond Issues 3/25/2014
CAP-CMV GmbH Raises New Funds To Further Develop Its Novel hCMV Vaccine And Appoints New CEO 3/24/2014
Entrepreneur Seamus Mulligan Cashes In $86 Million Of Jazz Pharmaceuticals plc (JAZZ) To Fund New Venture 3/21/2014
French Startup Inotrem Bags $25 Million To Develop Sepsis Drugs 3/14/2014
Viralytics Ltd (VLA.AX) Completes $27 Million Fund Raising 3/13/2014
Hainan Haiyao Announces $41 Million Pharma VC Fund 3/12/2014
Biotech Glycotope Manages To Squeeze $76 Million Out Of German Billionaires 3/12/2014
Bayer AG (BAYN.DE) To Inject $700 Million In Hemophilia A Drugs 3/11/2014
Immune Pharmaceuticals, Inc. Scores $11.7 Million Private Placement Financing 3/10/2014
Can-Fite BioPharma (CFBI) Completes $5 Million Private Placement 3/10/2014
Shanxi Taxus To Gain Control Of Cardium Therapeutics, Inc. (CXM) With $5 Million Investment 3/9/2014
Verona Pharma: - £13 Million Equity Issue, £1 Million Open Offer And Notice Of GM 3/7/2014
Kinex Pharmaceuticals Completes Oversubscribed $40 Million Private Placement Equity Raise 3/5/2014
Novo Nordisk A/S (NVO) Dumps Cash Into Pakistan 3/4/2014
InDex Pharmaceuticals AB Closes $20 Million Financing Round, Welcomes NeoMed As New Shareholder 2/25/2014
Invion Limited Announces Completion Of $5 Million Placement And Intention To Conduct $2 Million Rights Issue 2/21/2014
NovImmune SA Finishes $66 Million Series B Financing Round 2/18/2014
Oriola-KD Corporation Issues EUR 40 Million Hybrid Bond 2/13/2014
LabStyle Innovations Announces Pricing Of $4.19 Million Private Placement Financing 2/13/2014
Sanofi (France) (SAN.PA) Faces Scrutiny Over What It Plans To Do With Its Cash 2/13/2014
$115 Million+ GlaxoSmithKline (GSK)-Led European Program Targets Novel Antibiotics 2/12/2014
Rhenovia Secures Series B Funding 2/12/2014
Celsus Therapeutics (CLTX) Announces The Closing Of $9.2 Million Public Offering And Full Exercise Of Underwriter's Option To Purchase Additional Adss 2/6/2014
AbbVie (ABBV) To Invest $320 Million In First Asian Manufacturing Plant 2/6/2014
Anergis Closes Financing Round Totaling CHF 8 Million 2/5/2014
BerGenBio AS Wraps Up $12.5 Million Funding Round 2/5/2014
Viralytics Ltd (VLA.AX) Seeks $27 Million To Fund Cancer Trials 1/30/2014
Patrys Limited (PAB.AX) Raises A Further $0.9 Million 1/29/2014
OCR Raises €1 Million And Positions Itself As A Major Actor Of Comparative Medicine Human – Pets 1/28/2014
Provence Technologies And Provepharm Invest EUR 4 Million In Their New Head Office 1/27/2014
Genmab A/S (GEN.CO) Hauls In $182 Million+ In Private Funding 1/24/2014
RedHill Biopharma Ltd. (RDHL) Closes Previously Announced $11.7 Million Private Placement 1/22/2014
Synthelis Raises EUR 610,000 1/21/2014
Already-Rich Startup, Juno Therapeutics, Expands Series A Funding Round To $145 Million 1/15/2014
RedHill Biopharma Ltd. (RDHL) Announces Definitive Agreement For $11.7 Million Private Placement 1/14/2014
Starpharma Holdings Ltd To Recoup Additional $2 Million For Overseas R&D 1/14/2014
Investors Bet $22 Million On AC Immune SA, Will Start World's First Anti-Ptau Vaccine Trial For Alzheimer's Disease 1/10/2014
DiaGenic ASA Reduces Its Payment Obligations 1/10/2014
Kunshan RiboQuark Raises $7.5 Million For siRNA Projects 1/10/2014
GW Pharmaceuticals Secures $87.9 Million To Fund Epidiolex Development 1/9/2014
Apitope Led Consortium Receives Up To €6M FP7 Funding To Develop Novel Therapeutic Vaccine For Graves' Disease 1/8/2014
Minervax Release: Group B Streptococcal Vaccine For The Prevention Of Life-Threatening Infections In Newborns Secures Funding To Reach Clinical Proof Of Concept 1/8/2014
Quark Pharmaceuticals Inc. And Suzhou Ribo Life Science Raise Nearly RMB 45 Million For Newly Established Chinese Joint Venture 1/7/2014
New And Old Investors Bet $17.8 Million On Oregon State University 1/7/2014
RedHill Biopharma Ltd. (RDHL) Announces Definitive Agreement For $2.5 Million Private Placement From Broadfin Capital LLC 12/31/2013
RedHill Biopharma Ltd. (RDHL) Announces Definitive Agreement For $6.0 Million Private Placement From Orbimed Israel Partners Limited Partnership 12/30/2013
AmpliPhi Biosciences Corporation (APHB) Closes $18 Million Private Placement 12/27/2013
Oramed Pharmaceuticals Inc. (ORMP) Nets $15.8 Million In Direct Offering To Investors 12/27/2013
TiGenix Secures EUR 10 Million In Financing From Kreos Capital 12/23/2013
NeuroVive Pharmaceutical AB - SEK 35 M Private Placement Complete, More Information On Forthcoming SEK 75.8 M Rights Issue 12/18/2013
Crescendo Biologics Nabs $28 Million In Series A Financing 12/17/2013
AmpliPhi Biosciences Corporation (APHB) Announces $18 Million Private Placement 12/16/2013
Patrys Limited (PAB.AX) Raises $5.5 Million Following Closure Of Rights Issue 12/16/2013
Infect-ERA Allocates € 9 Million To European Transnational Research Projects In Infectious Diseases 12/16/2013
GlaxoSmithKline (GSK) To Spend $1 Billion To Lift Stakes In India, Nigeria Units 12/16/2013
AstraZeneca PLC (AZN)'s Delaware Site To Get $100 Million Facelift 12/13/2013
QRxPharma Pty Ltd. Completes A$11.6 Million Capital Raising 12/13/2013
Merck KGaA (MKGAF.PK)'s Unit Allergopharma Plans To Invest $55 Million In Production Facility 12/12/2013
GlaxoSmithKline (GSK) Pumps $330 Million More Into Manufacturing 12/11/2013
Covagen Locks In $47.2 Million Series B 12/10/2013
Powerful New Player, Alvotech, Dumps $250 Million In Biopharmaceuticals 12/6/2013
Zhejiang Hisun To Raise $328 Million To Increase Capacity 12/4/2013
MRCF Invests AU$1 Million In Antibiotics Start-Up Auspherix 12/3/2013
Telormedix Raises $6.6 Million In Series B Financing Round 12/2/2013
Bioaxial Secures EUR 1.9 Million (USD 2.7 Million) In New Funding To Finance The Commercialization Of Its First Range Of Super-Resolved Fluorescence Microscopy Instruments 11/27/2013
Bioxodes Raises EUR 2.6 Million (USD 3.5 Million) To Develop Antithrombotic Peptide Derived From Tick's Saliva 11/26/2013
TiGenix Completes EUR 12 Million Capital Increase With Strategic Investor Grifols 11/22/2013
Novartis AG (NVS) Reveals $5 Billion Share Buyback; Outlines New Pharmaceutical Biz Segments 11/22/2013
Avalon Ventures-GlaxoSmithKline (GSK) Launch Sitari Pharm With $10 Million Series A And R&D Support 11/22/2013
BioTie Therapies Corp.'s Loan Obligations To Tekes Reduced By EUR 2.8 Million 11/21/2013
TiGenix Raises EUR 12 Million Via A Private Placement Of New Ordinary Shares 11/20/2013
Innate Pharma (IPH.PA ): Raises [Eur]20.3 Million In A Private Placement Subscribed Entirely By US-Based Specialist Investors 11/20/2013
Cytos Biotechnology AG Rights Offering Oversubscribed - CHF 24.3 Million Raised 11/18/2013
GANYMED Pharmaceuticals AG Scrounges Up $60 Million Financing Round 11/18/2013
Pfizer Inc. (PFE) Sees Something Special In MissionTherapeutics Ltd, Backs Co With $32 Million Series B 11/18/2013
GlaxoSmithKline (GSK) To Set Up New £85 Million Unit In India 11/15/2013
Merck KGaA (MKGAF.PK) Invests $107 Million In China Drug Plant 11/15/2013
Eli Lilly and Company (LLY) Will Invest $350 Million In China Diabetes Cartridge Facility 11/14/2013
QRxPharma Pty Ltd. Announces Successful Completion Of A$7.5 Million Placement 11/13/2013
Teva Pharmaceutical Industries Limited (TEVA) To Cough Up $565 Million In Israeli Taxes 11/12/2013
China New Enterprise Invests Additional $25 Million in Shanghai Fudan-Zhangjiang 11/8/2013
Gansu Duyiwei Pays $16.6 Million for Sichuan Huaji Pharma 11/8/2013
Simavita Launches IPO to Raise A$15 Million and Commences Listing on TSXV 11/4/2013
arGEN-X Raises EUR 5 Million From PMV in Extension of EUR 32.5 Million Series B 11/4/2013
Hookipa Biotech Nabs $27.5 Million in Series B Financing 11/4/2013
Nexvet Raises $7 Million From International Investor Syndicate in Oversubscribed Capital Raise 10/29/2013
Bicoll GmbH Receives First Payment as Member of the €11.5 Million EU Funded Epimirna Project to Develop Novel Epilepsy Therapeutics 10/29/2013
Imugene Limited (IMU.AX) Capital Raising Complete 10/23/2013
THERAVECTYS Raises $20 Million 10/16/2013
SAGE Therapeutics Secures $20 Million Series B Financing 10/16/2013
immatics biotechnologies GmbH Snags $46 Million in Series D Financing Round 10/15/2013
Nosopharm Receives EUR 870,000 (USD 1.18 Million) to Help Combat Antibiotic Resistance 10/15/2013
ASLAN Pharmaceuticals Pte Ltd Raises $22 Million in B Round 10/10/2013
IP Group Completes £5 Million Investment in Cambridge Innovation Capital; Signs MoU to Facilitate Access to Co-Investment Opportunities 10/10/2013
Pharming Group (PHGUF.PK) Announces €12.0 Million Private Equity Placement With Institutional Investors 10/9/2013
Healios K.K. Lands $30.6 Million Capital Raise 10/8/2013
Novo Nordisk A/S (NVO) to Inject Up to $3.7 Billion on Diabetes Pills 10/7/2013
Pharmalink AB Snags $15 Million to Undertake Pivotal Studies With Lead Programs in Cancer Therapy and Renal Disease 10/4/2013
Merus Lands $42 Million Series B 10/3/2013
Opsona Therapeutics Ltd. Raises an Additional $4 Million Series C From Omnes Capital 10/2/2013
Celsus Therapeutics Closes $12.5 Million Private Placement 10/1/2013
Aesica Unveils a New High Capacity Manufactuting Facility Investing £30 Million at Its Queenborough , UK Site 9/19/2013
Celsus Therapeutics Announces $12.5 Million Private Placement 9/19/2013
MorphoSys AG Nabs $126 Million to Fund Clinical Programs 9/19/2013
Tianjin CanSino Biotech Raises $10 Million From Lilly Asia Ventures 9/17/2013
Bayer AG (BAYN.DE) Needs to Cut Costs: CEO Says 9/17/2013
Protalix Biotherapeutics, Inc. (PLX) Announces Proposed $60 Million Offering of Convertible Notes 9/12/2013
Imperial Innovations Leads £8 Million Series "C" Funding Round in Plaxica 9/10/2013
DuecomplusA Release: UK-Swedish Team Turn to Crowdfunding for Promising New QS Nanoparticle-Based Leukemia Treatment 9/10/2013
DRI Capital Raises $1.45 Billion to Buy More Drug Royalties 9/9/2013
Almac Group and Queen’s University, Belfast Announce £13 Million Investment in Cancer Research 9/5/2013
Mind-NRG Successfully Completes 6 Million Euro (~8 Million USD) Series B Financing 9/4/2013
Arsanis, Inc. Closes $20 Million Series B Financing 9/3/2013
Mimetica $6.5 Million ASX Listing to Develop Topical Acne Treatment 9/3/2013
LEUKOCARE Announces EUR 3.4 Million Capital Increase 9/3/2013
Acacia Pharma Raises $23.5 Million to Advance Clinical Development of Lead Products for Supportive Care 9/3/2013
Evotec AG (EVTG.F) Raises $40 Million From Biotechnology Value Fund; Stock Up +10.60% at Market Close (September 3, 2013) 9/3/2013
Prime Minister Kevin Rudd Announces New $250 Million Biotech Fund 8/26/2013
Cyprotex (COTXF.PK) Subscription Agreement 8/21/2013
Vexim Strengthens Its Equity Capital by €2.5 Million Via an Investment by Truffle Capital 8/12/2013
Addex Therapeutics (ADXN.SW) Raises $3.4 Million in a Private Placement to International Institutional Investors 8/9/2013
Shenogen Pharma Group of Beijing Raises $20 Million in C Round 8/6/2013
Biomedical Catalyst Awards and National Biologics Manufacturing Center Will Support the Future of the UK Bioscience Sector 7/31/2013
Harbour Antibodies BV Raises €2.5M ($3.3M) to Accelerate the Development of Monoclonal Antibody Therapies 7/24/2013



//-->